COVID-19 causes more blood clots than the vaccines, UK study

COVID-19 causes more blood clots than the vaccines, UK study

There is an increased risk of brain blood clots from the COVID-19 virus than there is from its vaccines. This is according to British researchers after the vaccine administration was suspended due to blood clots cases.  

The widely used vaccines against Covid-19, AstraZeneca, and Johnson & Johnson have both been linked to cerebral venous sinus thrombosis (CVST). In the US, the administration of the Johnson & Johnson vaccine was suspended pending investigations of blood clots while in Denmark, the use of AstraZeneca was stopped forthwith due to blood clots.      

However, drug regulators from both Britain and Europe have emphasized the fact that the benefits of the Covid-19 surpass associated vaccine risks. 

 This follows a study of about 500,000 patients where it was established that the occurrence of CVST was at a rate of 39 per a million people after infection. Comparatively, the European Medicines Agency (EMA) also showed that 5 in a million people had CVST after the AstraZeneca jab.

According to the researchers, the risks associated with CVST are 8-10 times higher when infected with Covid-19 than it is from the Covid-19 vaccines.

In other words, the risks of having CVST upon contacting Covid-19 are higher than the risks associated with the Oxford-AstraZeneca vaccine.

Furthermore, the research intimated that the mortality rate due to CVST is around 20% whether caused by Covid-19 or the vaccine. This means that blood clots are a great risk factor.

It was also established that the level of platelet was lower than expected caused by the vaccine but not yet known whether Covid-19 infection also causes a reduction in platelets.

According to these researchers, Covid-19 causes more clotting disorders than CVST like strokes, and the ongoing discourse concerning the vaccine has blinded the risks associated with Covid-19.